Boost therapy of hepatocellular carcinoma by amplifying vicious cycle between mitochondrial oxidative stress and endoplasmic reticulum stress via biodegradable ultrasmall nanoparticles and old drug

氧化应激 内质网 线粒体 化学 药品 癌症研究 肝细胞癌 细胞生物学 纳米颗粒 压力(语言学) 药理学 生物物理学 纳米技术 医学 材料科学 生物化学 生物 语言学 哲学
作者
Hao Zhang,Tingting Wang,Hanghang Liu,Yaobao Han,Qing Yin Zheng,Qi Xu,Bolin Bao,Wei Xing,Zhen Li
出处
期刊:Nano Today [Elsevier BV]
卷期号:46: 101601-101601 被引量:25
标识
DOI:10.1016/j.nantod.2022.101601
摘要

Despite advances in early diagnosis and treatment of hepatocellular carcinoma (HCC), HCC shows a very high mortality and development of innovative drugs and treatment methods are highly desirable. Herein, we report an innovative therapy of HCC through the formation and amplification of vicious cycle between mitochondrial oxidative stress and ER stress by joint use of biodegradable ultrasmall Cu 2- x Se nanoparticles (CS NPs) and alcohol-abuse drug disulfiram (DSF). The CS NPs can alleviate the tumor hypoxia and generate reactive oxygen species (ROS) through their Fenton-like reaction with endogenous H 2 O 2 in tumor. Their released copper ions can react with DSF to in situ form active drug CuET to significantly suppress the growth of HCC and exhibit excellent anti-tumor effect. We reveal the novel anti-tumor mechanism of the formed CuET complex, which can immobilize nuclear protein localization protein 4 (NPL4) to inhibit the proteasome system to induce endoplasmic reticulum (ER) stress and increase the burden of Ca 2+ ions in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. The mitochondrial oxidative stress produces less ATP to induce the occurrence of autophagy, and the generated ROS further strengthens the ER stress. The formation of such vicious cycle between mitochondrial oxidative stress and ER stress significantly enhances the severe apoptosis of tumor cells and notable decrease in tumor size, which has been demonstrated in both subcutaneous and orthotopic HCC models. Our work provides insights into repurposing of metabolic nanoparticles and old drugs for new applications, demonstrates the great potential of this strategy in anti-tumor therapy. • Joint use of Cu2-xSe NPs and disulfiram can suppress HCC growth due to the in situ formation of anti-tumor drug CuET. • The CuET can cause and amplify a vicious cycle between ER stress and mitochondrial oxidative stress. • The ER stress increases the burden of Ca2+ in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. • The mitochondrial damage produces less ATP to induce autophagy, and the burst of ROS further strengthens the ER stress.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
Cenhuan发布了新的文献求助10
1秒前
努力地小夏完成签到,获得积分10
1秒前
1秒前
2秒前
852应助wshengnan采纳,获得10
2秒前
李梦茹完成签到,获得积分20
2秒前
3秒前
Mr.Bad发布了新的文献求助10
4秒前
zzdd完成签到,获得积分10
4秒前
缓慢的箴完成签到,获得积分10
4秒前
Aza发布了新的文献求助10
4秒前
5秒前
5秒前
深情安青应助窦潞娜采纳,获得10
5秒前
Zzy发布了新的文献求助10
6秒前
皮皮完成签到,获得积分10
7秒前
李梦茹发布了新的文献求助10
7秒前
打打应助小鳗鱼采纳,获得10
7秒前
9秒前
qin发布了新的文献求助10
9秒前
陈北风完成签到,获得积分10
9秒前
李健的小迷弟应助yang采纳,获得10
9秒前
kittency完成签到 ,获得积分10
9秒前
AZMARS完成签到,获得积分10
9秒前
10秒前
刘嘎嘎发布了新的文献求助10
11秒前
AZMARS发布了新的文献求助10
11秒前
12秒前
RenWeng发布了新的文献求助10
12秒前
12秒前
陈北风发布了新的文献求助10
12秒前
尹淑完成签到,获得积分10
13秒前
13秒前
张英歌发布了新的文献求助10
13秒前
zz完成签到,获得积分10
13秒前
15秒前
隐形曼青应助抹茶采纳,获得10
15秒前
十一完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Metallurgy at high pressures and high temperatures 2000
Tier 1 Checklists for Seismic Evaluation and Retrofit of Existing Buildings 1000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 1000
The Organic Chemistry of Biological Pathways Second Edition 1000
Free parameter models in liquid scintillation counting 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6331207
求助须知:如何正确求助?哪些是违规求助? 8147642
关于积分的说明 17097357
捐赠科研通 5386893
什么是DOI,文献DOI怎么找? 2855989
邀请新用户注册赠送积分活动 1833404
关于科研通互助平台的介绍 1684813